These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

849 related articles for article (PubMed ID: 29402765)

  • 1. Computed Tomography Perfusion Derived Blood-Brain Barrier Permeability Does Not Yet Improve Prediction of Hemorrhagic Transformation.
    Horsch AD; Bennink E; van Seeters T; Kappelle LJ; van der Graaf Y; Mali WPTM; de Jong HWAM; Velthuis BK; Dankbaar JW;
    Cerebrovasc Dis; 2018; 45(1-2):26-32. PubMed ID: 29402765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-brain barrier permeability assessed by perfusion computed tomography predicts hemorrhagic transformation in acute reperfusion therapy.
    Kim T; Koo J; Kim SH; Song IU; Chung SW; Lee KS
    Neurol Sci; 2018 Sep; 39(9):1579-1584. PubMed ID: 29909558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Prognostic Value of CT Angiography and CT Perfusion in Acute Ischemic Stroke.
    van Seeters T; Biessels GJ; Kappelle LJ; van der Schaaf IC; Dankbaar JW; Horsch AD; Niesten JM; Luitse MJ; Majoie CB; Vos JA; Schonewille WJ; van Walderveen MA; Wermer MJ; Duijm LE; Keizer K; Bot JC; Visser MC; van der Lugt A; Dippel DW; Kesselring FO; Hofmeijer J; Lycklama À Nijeholt GJ; Boiten J; van Rooij WJ; de Kort PL; Roos YB; van Dijk EJ; Pleiter CC; Mali WP; van der Graaf Y; Velthuis BK;
    Cerebrovasc Dis; 2015; 40(5-6):258-69. PubMed ID: 26484857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral Microbleeds are an Independent Predictor of Hemorrhagic Transformation Following Intravenous Alteplase Administration in Acute Ischemic Stroke.
    Nagaraja N; Tasneem N; Shaban A; Dandapat S; Ahmed U; Policeni B; Olalde H; Shim H; Samaniego EA; Pieper C; Ortega-Gutierrez S; Leira EC; Adams HP
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1403-1411. PubMed ID: 29398533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
    Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
    Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low Alberta stroke program early computed tomography score within 3 hours of onset predicts subsequent symptomatic intracranial hemorrhage in patients treated with 0.6 mg/kg Alteplase.
    Hirano T; Sasaki M; Tomura N; Ito Y; Kobayashi S;
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):898-902. PubMed ID: 21737309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Value of Whole-Brain Perfusion Parameters Combined with Multiphase Computed Tomography Angiography in Predicting Hemorrhagic Transformation in Ischemic Stroke.
    Li X; Liu H; Zeng W; Liu X; Wen Y; Xiong Q; Yang R
    J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104690. PubMed ID: 32067854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between stroke severity, patient characteristics and CT-perfusion derived blood-brain barrier permeability measurements in acute ischemic stroke.
    Horsch AD; Dankbaar JW; van Seeters T; Niesten JM; Luitse MJ; Vos PC; van der Schaaf IC; Biessels GJ; van der Graaf Y; Kappelle LJ; Mali WP; Velthuis BK
    Clin Neuroradiol; 2016 Dec; 26(4):415-421. PubMed ID: 25722019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased blood-brain barrier permeability on perfusion computed tomography predicts hemorrhagic transformation in acute ischemic stroke.
    Ozkul-Wermester O; Guegan-Massardier E; Triquenot A; Borden A; Perot G; Gérardin E
    Eur Neurol; 2014; 72(1-2):45-53. PubMed ID: 24853726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood-brain barrier permeability assessed by perfusion CT predicts symptomatic hemorrhagic transformation and malignant edema in acute ischemic stroke.
    Hom J; Dankbaar JW; Soares BP; Schneider T; Cheng SC; Bredno J; Lau BC; Smith W; Dillon WP; Wintermark M
    AJNR Am J Neuroradiol; 2011 Jan; 32(1):41-8. PubMed ID: 20947643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.
    Olindo S; Chardonnet M; Renou P; Coignion C; Debruxelles S; Poli M; Sagnier S; Rouanet F; Sibon I
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):454-459. PubMed ID: 29128327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT perfusion analysis by nonlinear regression for predicting hemorrhagic transformation in ischemic stroke.
    Bennink E; Horsch AD; Dankbaar JW; Velthuis BK; Viergever MA; de Jong HW
    Med Phys; 2015 Aug; 42(8):4610-8. PubMed ID: 26233188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
    Ong CT; Wong YS; Wu CS; Su YH
    Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of Collaterals is Associated with Larger Infarct Volume and Worse Outcome in Patients with Large Vessel Occlusion and Mild Symptoms.
    Kimmel ER; Al Kasab S; Harvey JB; Bathla G; Ortega-Gutierrez S; Toth G; Jaksich EM; Sheharyar A; Roa J; Hasan DM; Samaniego EA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1987-1992. PubMed ID: 31036341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemorrhagic transformation of ischemic stroke: prediction with CT perfusion.
    Aviv RI; d'Esterre CD; Murphy BD; Hopyan JJ; Buck B; Mallia G; Li V; Zhang L; Symons SP; Lee TY
    Radiology; 2009 Mar; 250(3):867-77. PubMed ID: 19244051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collateral flow averts hemorrhagic transformation after endovascular therapy for acute ischemic stroke.
    Bang OY; Saver JL; Kim SJ; Kim GM; Chung CS; Ovbiagele B; Lee KH; Liebeskind DS;
    Stroke; 2011 Aug; 42(8):2235-9. PubMed ID: 21737798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.
    Spokoyny I; Raman R; Ernstrom K; Meyer BC; Hemmen TM
    J Stroke Cerebrovasc Dis; 2014; 23(5):1046-50. PubMed ID: 24103663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten-Year Evaluation of the TOYOTA Prehospital Stroke Scale for Tissue Plasminogen Activator Intravenous Therapy in the Real World.
    Suzuki J; Nakai N; Kondo N; Tsuji H; Inagaki R; Furukawa S; Iwata M; Nishida S; Ito Y
    Cerebrovasc Dis; 2018; 46(3-4):184-192. PubMed ID: 30384371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.